It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2005.
2005 | Ahmedabad, Gujarat, India | ActiveAdmit Pharmaceuticals Private Limited, a active private limited company, was established on 24 March 2005 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230GJ2005PTC045758. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.91 M.
It upholds a compliant status. Its leadership includes Mahesh Ghughabhai Paradava (Director), Mehul Babubhai Katariya (Director). Past directors included Dimpleben Panjwani, Naresh Sevakram Panjwani, Mayur Kanjibhai Katariya. It holds no open charges and ₹5.45 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ll/3, Basement, Man Sarovar Near Octroi Naka, Nikol Gam Road,Nikol, Ahmedabad, Gujarat, 380051.
U24230GJ2005PTC045758
045758
24 March 2005
₹1.00 M
₹0.91 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Admit Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahesh Ghughabhai Paradava | Director | 25 Jul 2015 | Current |
| Mehul Babubhai Katariya | Director | 28 Mar 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 30 Mar 2010 | Past |
| Pramod Abcsdd | Director | 25 Jul 2015 | Past |
| Pramod Abcsdd | Director | 30 Mar 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Admit Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 63.31% decrease. The company also saw a substantial fall in profitability, with a 73.53% decrease in profit. The company's net worth moved up by a moderate rise of 1.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Admit Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2010 | Indian Bank | ₹2.20 M | Satisfied |
| 25 Mar 2009 | Vijay Commercialco-Operative Bank Limited | ₹2.00 M | Satisfied |
| 11 May 2006 | Vijay Commercial Co-Operative Bank Limited | ₹1.25 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Admit Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Admit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Admit Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Admit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Admit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity Mahesh Ghughabhai Paradava was appointed as a Director was appointed as a Director on 25 Jul 2015 & has been associated with this company since 10 years 4 months . was completed.
Progress on Mehul Babubhai Katariya was appointed as a Director was appointed as a Director on 28 Mar 2013 & has been associated with this company since 12 years 8 months . was documented.
A charge registered on 11 May 2006 via Charge ID 10012451 with Vijay Commercial Co-Operative Bank Limited was fully satisfied on 18 Feb 2013. was recorded as a recent event.
The activity A charge registered on 05 Jul 2010 via Charge ID 10259787 with Indian Bank was fully satisfied on 11 Feb 2013. was completed.
The CIN of Admit Pharmaceuticals Private Limited is U24230GJ2005PTC045758.
Admit Pharmaceuticals Private Limited is headquartered at Ll/3, Basement, Man Sarovar Near Octroi Naka, Nikol Gam Road,Nikol, Ahmedabad, Gujarat, 380051.
Admit Pharmaceuticals Private Limited was incorporated on 24 March 2005.
The current directors of Admit Pharmaceuticals Private Limited are
The primary industry of Admit Pharmaceuticals Private Limited is Trade.
Admit Pharmaceuticals Private Limited is unlisted.
The authorized capital of Admit Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.91 M.
The compliance status of Admit Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX